Pharmaceutical drug development services; drug screening services, namely, scientific research to identify synergistic or antagonistic interactions between small-molecule drugs, therapeutic antibodies and proteins for therapeutic purposes

Pharmaceuticals, in particular, combination therapeutic compositions in the nature of metabolism-modulating therapeutics for the treatment of metabolic diseases

Pharmaceuticals, in particular, combination therapeutic compositions in the nature of anti-inflammatories for the treatment of immunological diseases and immunomodulators for the treatment of immunological diseases

Pharmaceuticals, in particular, combination therapeutic compositions in the nature of antiproliferatives for the treatment of hyperproliferative diseases, anticancertherapeutics for the treatment of cancer, neuroprotectants for the treatment of neurodegenerative diseases, and anti-infectives for the treatment of infectious diseases